Patent · US Active

Small molecule antagonists of bacterial quorum-sensing receptors

US8772331B2 · kind B2 · utility

1Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2012
Grant dateJul 8, 2014
Priority date
Expiry dateJul 17, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A novel small molecule antagonizes two types of acyl homoserine lactone receptors: membrane-bound and cytoplasmic. A focused library of analogs and derivatives of the original antagonist was synthesized. Analog and derivative molecules harbor a range of activities. The novel small molecule and most potent antagonist protects the eukaryote Caenorhabditis elegans from quorum-sensing-mediated killing by the bacterial pathogen Chromobacterium violaceum. The saving of C. elegans demonstrates the use of these molecules as small molecule antimicrobials.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.